Table 4 Cross-tabulation of individual CMRFs (ACR, eGFR, and Obesity) with the variables in study.

From: Geographic variation in cardiometabolic risk factor prevalence explained by area-level disadvantage in the Illawarra-Shoalhaven region of the NSW, Australia

CMRFs

ACR

eGFR

Obesity

Total tests

Higher risk* results, n (%)

Total tests

Higher risk* results, n (%)

Total tests

Higher risk* results, n (%)

Rates

50,737

2046 (4.03)

243,908

27,205 (11.15)

192,261

64,875 (33.7)

Sex

Male

25,043

1,265 (2.49)

108,140

12,441 (5.1)

86,853

29,585 (15.3)

Female

25,694

781 (1.54)

135,768

14,764 (6.05)

105,408

35,290 (18.3)

Age (years)

18–29

1546

47 (0.09)

32,961

72 (0.03)

23,277

4,582 (2.38)

30–39

2,278

71 (0.14)

29,047

105 (0.04)

22,799

6,535 (3.40)

40–49

4,870

108 (0.21)

35,778

330 (0.14)

30,401

10,595 (5.51)

50–59

9,272

230 (0.45)

42,695

1,112 (0.46)

37,285

13,825 (7.19)

60–69

13,388

412 (0.81)

43,423

3,626 (1.49)

38,370

15,310 (7.96)

70–79

12,337

605 (1.19)

34,406

8,507 (3.49)

30,074

11,324 (5.89)

80+

7,046

573 (1.13)

25,598

13,453 (5.52)

10,055

2,704 (1.41)

IRSD

Most D Q-1

11,915

638 (1.26)

49,288

7,061 (2.89)

37,476

15,365 (7.99)

Q-2

11,350

485 (0.96)

52,947

6,354 (2.61)

40,172

14,334 (7.46)

Q-3

10,494

391 (0.77)

50,816

5,917 (2.43)

39,133

13,007 (6.77)

Q-4

8,732

308 (0.61)

46,440

4,406 (1.81)

37,370

11,766 (6.12)

Least D Q-5

8,246

224 (0.44)

44,417

3,467 (1.42)

38,110

10,403 (5.41)

  1. ACR Albumin Creatinine Ratio, eGFR estimated Glomerular Filtration Rate, BMI Body Mass Index, Most D Most Disadvantaged, Least D Least Disadvantaged.
  2. *Refer to Table 1 for higher risk threshold levels of CMRFs.